Efficacy and Safety in Patients With Type 2 Diabetes Mellitus, Cardiovascular Disease and Hypertension

Clinical trial NCT01031680 · COMPLETED

Trial details

NCT number: NCT01031680
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus Cardiovascular Disease Hypertension Inadequate Glycaemic Control

Start date: 2010-02-01
Primary completion: 2011-05-01
Enrollment: 922

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.